| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada V6H 3V5
Address all correspondence and requests for reprints to: Peter C. K. Leung, Ph.D., Department of Obstetrics and Gynecology, University of British Columbia, Room 2H-30, 4490 Oak Street, Vancouver, British Columbia, Canada V6H 3V5. E-mail: peleung{at}interchange.ubc.ca.
An intricate balance between the production of matrix metalloproteinases (MMPs) and their endogenous inhibitors, tissue inhibitors of metalloproteinases (TIMPs), modulates the overall proteolytic activity of trophoblasts during human implantation. In these studies we have examined the ability of classical GnRH I and the second form of this hormone (GnRH II) to regulate MMP-2, MMP-9, and TIMP-1 mRNA and protein levels in extravillous cytotrophoblasts propagated from explants of first trimester chorionic villi. GnRH I and GnRH II were found to increase MMP-2 and MMP-9 mRNA and protein levels in these primary cell cultures in a dose- and time-dependent manner using quantitative competitive-PCR and ELISA. In contrast, these two hormones decreased trophoblastic TIMP-1 mRNA and protein levels. Cetrorelix, a GnRH receptor antagonist, inhibited the regulatory effects of GnRH I, but not GnRH II, on MMP-2, MMP-9, and TIMP-1 expression in these cells. Collectively, these observations suggest that GnRH I and GnRH II differentially regulate MMP-2, MMP-9, and TIMP-1 expression in human trophoblasts, possibly via distinct receptor-mediated intracellular signaling pathways.
This work was supported by an operating grant from the Canadian Institutes of Health Research (to P.C.K.L. and C.D.M.).
C.D.M. and P.C.K.L. contributed equally to these studies.
C.D.M. is a career investigator with the British Columbia Research Institute for Children’s and Women’s Health.
P.C.K.L. is the recipient of a distinguished senior investigatorship scholar award from the Michael Smith Foundation for Health Research.
Abbreviations: EVT, Extravillous cytotrophoblast; FBS, fetal bovine serum; GnRHR, GnRH receptor; MMP, matrix metalloproteinase; QC-PCR, quantitative competitive-PCR; TIMP, tissue inhibitor of metalloproteinases; uPA, urokinase plasminogen activator.
This article has been cited by other articles:
 |
|
 |
|
  J. Liu, C. D. MacCalman, Y.-l. Wang, and P. C. K. Leung Promotion of Human Trophoblasts Invasion by Gonadotropin-Releasing Hormone (GnRH) I and GnRH II via Distinct Signaling Pathways Mol. Endocrinol., July 1, 2009; 23(7): 1014 - 1021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Pearce Multifunctional angiogenic factors: add GnRH to the list. Focus on "Gonadotropin-releasing hormone-regulated chemokine expression in human placentation" Am J Physiol Cell Physiol, July 1, 2009; 297(1): C4 - C5. [Full Text] [PDF]
|
|
|
|
|
|
P. C. Cavanagh, C. Dunk, M. Pampillo, J. M. Szereszewski, J. E. Taylor, C. Kahiri, V. Han, S. Lye, M. Bhattacharya, and A. V. Babwah Gonadotropin-releasing hormone-regulated chemokine expression in human placentation Am J Physiol Cell Physiol, July 1, 2009; 297(1): C17 - C27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Poon, B.-S. An, W.-K. So, G. L. Hammond, and P. C. K. Leung Temporal Recruitment of Transcription Factors at the 3',5'-Cyclic Adenosine 5'-Monophosphate-Response Element of the Human GnRH-II Promoter Endocrinology, October 1, 2008; 149(10): 5162 - 5171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Morimoto, Y. Osuga, T. Yano, Y. Takemura, M. Harada, T. Hirata, Y. Hirota, O. Yoshino, K. Koga, K. Kugu, et al. GnRH II as a possible cytostatic regulator in the development of endometriosis Hum. Reprod., November 1, 2005; 20(11): 3212 - 3218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Rajashekhar, A. Loganath, A. C. Roy, S. S. Chong, and Y. C. Wong Hypoxia Up-regulated Angiogenin and Down-regulated Vascular Cell Adhesion Molecule-i Expression and Secretion in Human Placental Trophoblasts Reproductive Sciences, July 1, 2005; 12(5): 310 - 319. [Abstract] [PDF]
|
|
|
|
 |
|
 C. K. Cheng and P. C. K. Leung Molecular Biology of Gonadotropin-Releasing Hormone (GnRH)-I, GnRH-II, and Their Receptors in Humans Endocr. Rev., April 1, 2005; 26(2): 283 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G S Harrison, M E Wierman, T M Nett, and L M Glode Gonadotropin-releasing hormone and its receptor in normal and malignant cells Endocr. Relat. Cancer, December 1, 2004; 11(4): 725 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ding, J. Xu, X. Luo, and N. Chegini Gonadotropin Releasing Hormone and Transforming Growth Factor {beta} Activate Mitogen-Activated Protein Kinase/Extracellularly Regulated Kinase and Differentially Regulate Fibronectin, Type I Collagen, and Plasminogen Activator Inhibitor-1 Expression in Leiomyoma and Myometrial Smooth Muscle Cells J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5549 - 5557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Luo, L. Ding, and N. Chegini Gonadotropin-releasing hormone and TGF-{beta} activate MAP kinase and differentially regulate fibronectin expression in endometrial epithelial and stromal cells Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E991 - E1001. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Kauffman and E. F. Rissman A Critical Role for the Evolutionarily Conserved Gonadotropin-Releasing Hormone II: Mediation of Energy Status and Female Sexual Behavior Endocrinology, August 1, 2004; 145(8): 3639 - 3646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-S. Chou, A. G. Beristain, C. D. MacCalman, and P. C. K. Leung Cellular Localization of Gonadotropin-Releasing Hormone (GnRH) I and GnRH II in First-Trimester Human Placenta and Decidua J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1459 - 1466. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
